Semaglutide belongs to a group of medicines known as GLP-1 receptor agonists
Taken together, these findings suggest that combining GLP-1 and estrogen signaling does not simply add two neuroprotective effects together
In summary, these investigations highlight the multifaceted role of GLP-1 in enhancing -cell regeneration and functionality, particularly in stressful environments such as T1D, and support its use as a potential treatment strategy for -cell replacement and diabetes management
NAD+ IV therapy supports a different but complementary set of mechanisms primarily cellular energy and DNA repair and is often used alongside neuropeptide protocols
Research with larger samples and in different regions is needed to elucidate the genes and polymorphisms related to the action of lithium globally, and thus, to be able to implement the pharmacogenetic evaluation of individuals in clinical practice, ensuring that lithium has the necessary efficacy